Replies to post #164 on Huifeng Bio-pharmaceutical Technology (fka HFGB)

[pappy]

If it was these guys you may get another chance to buy cheap shares.

As no U.S. investors would seem to have a reason to sell at $0.59 that I am aware of.

In early Nov. Xi'an Runfeng Investment,Ltd. was issued 861,606 shares instead of cash for the $516,964 owed as of Oct. 30 2010.

HFGB has payed back debt with shares in the past & it seems vendors & some of these Chinese Investment companies prefer cash with little regard to the pps they receive.

As cashflow starts to catch up with the amount of money needed to finance growth I hope hfgb stops this practice.

But in the meantime investors with a longerterm outlook may get a chance to buy some more cheap shares.

I have noticed since hfgb upped guidance that the pps has not reacted very positive.

Thus if my opinion proves correct Xi'an may have already sold some shares before today so its hard to say how many shares still overhang the market.

With U.S. markets in tax-loss selling season these Chinese seem to have no sense about timing stock sells.

Since I still believe the pps of hfgb deserves to be North not South of $1.00 I may join you in buying some cheap shares however we may have until yearend to pick a buying pps to add shares if I am correct.

This old fart is often wrong so don't read to much into the thoughts I am putting out there.